View Now: IBD Biomarker Regulatory Science Webinar
Wednesday, March 10, 10 a.m. ET
The 3TR IMI project consortium and Critical Path Institute invite you to participate in the IBD Biomarker Regulatory Science Webinar. Together, with a collection of public research institutes, industry members and patient advocates, we will align on how to progress biomarkers through the FDA & EMA’s regulatory acceptance process. This webinar will include key stakeholders from the IBD medical community focused on establishing a partnership to facilitate the progression of IBD biomarkers through regulatory acceptance.
To view all the pre-recorded presentations and panel discussions, visit: https://c-path.org/ibd-biomarker-regulatory-science-webinar/.